|
1) 日本透析医学会統計調査委員会. わが国の慢性透析療法の現況(2005年12月31日現在). 透析会誌. 2007; 40: 1-30
|
|
|
|
|
2) Shimazaki A, Kawamura Y, Kanazawa A, et al. Genetic variations in the gene encoding engulfment and cell motility 1 (ELMO1) are associated with susceptibility to diabetic nephropathy. Diabetes. 2005; 54: 1171-8
|
|
|
|
|
3) International Human Genome Sequencing Consortium. Finishing the euchromatic sequence of the human genome. Nature. 2004; 431: 931-45
|
|
|
|
|
|
4) The International SNP Map Working Group. A map of human genome sequence variation containing 1. 42 million single nucleotide polymorphisms. Nature. 2001; 409: 928-33
|
|
|
|
|
|
5) The International HapMap Consortium. A haplotype map of the human genome. Nature. 2005; 437: 1299-320
|
|
|
|
|
|
6) Wellcome Trust Case Control Consortium. Genome-wide association study of 14, 000 cases of seven common diseases and 3, 000 shared controls. Nature. 2007; 447: 661-78
|
|
|
|
|
|
7) Sladek R, Rocheleau G, Rung J, et al. A genome-wide association study identifies novel risk loci for type 2 diabetes. Nature. 2007; 445: 881-5
|
|
|
|
|
|
8) Hakonarson H, Grant SF, Bradfield JP, et al. A genome-wide association study identifies KIAA0350 as a type 1 diabetes gene. Nature. 2007; [Epub ahead of print]
|
|
|
|
|
|
9) Winkelmann J, Schormair B, Lichtner P, et al. Genome-wide association study of restless legs syndrome identifies common variants in three genomic regions. Nat Genet. 2007; [Epub ahead of print]
|
|
|
|
|
|
10) Maeda S. Genome-wide search for susceptibility gene to diabetic nephropathy by gene-based SNP. Diabetes Res Clin Pract. 2004; 66 (Suppl 1): S45-7
|
|
|
|
|
|
11) Maeda S, Osawa N, Hayashi T, et al. Genetic variations associated with diabetic nephropathy and type 2 diabetes in a Japanese population. Kidney Int. 2007; 72: S43-8
|
|
|
|
|
|
12) Tanaka N, Babazono T, Saito S, et al. Association of solute carrier family 12 (sodium/chloride) member 3 with diabetic nephropathy, identified by genome-wide analyses of single nucleotide polymorphisms. Diabetes. 2003; 52: 2848-53
|
|
|
|
|
|
13) Kamiyama M, Kobayashi M, Araki S, et al. Polymorphisms in the 3'UTR in the neurocalcin - gene affect mRNA stability, and confer susceptibility to diabetic nephropathy. Human Genetics. 2007: In press
|
|
|
|
|
|
14) Gumienny TL, Brugnera E, Tosello-Trampont AC, et al. CED-12/ELMO, a novel member of the CrkII/Dock180/Rac pathway, is required for phagocytosis and cell migration. Cell. 2001; 107: 27-41
|
|
|
|
|
|
15) Brugnera E, Haney L, Grimsley C, et al. Unconventional Rac-GEF activity is mediated through the Dock180-ELMO complex. Nature Cell Biol. 2002; 4: 574-82
|
|
|
|
|
|
16) Blattner SM, Kretzler M. Integrin-linked kinase in renal disease: connecting cell-matrix interaction to the cytoskeleton. Curr Opin Nephrol Hypertens. 2005; 14: 404-10
|
|
|
|
|
|
17) Cox BD, Natarajan M, Stettner MR, et al. New concepts regarding focal adhesion kinase promotion of cell migration and proliferation. J Cell Biochem. 2006; 99: 35-52
|
|
|
|
|
|
18) Playford MP, Schaller MD. The interplay between Src and integrins in normal and tumor biology. Oncogene. 2004; 23: 7928-46
|
|
|
|
|
|
19) Shimazaki A, Tanaka Y, Shinosaki T et al. ELMO1 increases expression of extracellular matrix (ECM) proteins and inhibits cell adhesion to ECMs. Kidney Int. 2006; 70: 1769-76
|
|
|
|
|
|
20) Wiggins RC. The spectrum of podocytopathies: a unifying view of glomerular diseases. Kidney Int. 2007; 71: 1205-14
|
|
|
|
|
|
21) Wolf G, Ziyadeh FN. Cellular and molecular mechanisms of proteinuria in diabetic ne-phropathy. Nephron Physiol. 2007; 106: 26-31
|
|
|
|
|